The protective effect of hispidin against hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblast cells through Akt/GSK-3β and ERK1/2 signaling pathway

Experimental Cell Research

Volumn 327, Issue 2, 2014, Pages 264-275

  Kim, Dae Eun ^a,d   Kim, Bokyung ^b   Shin, Hwa Sup ^c   Kwon, Ho Jeong ^a,e   Park, Eun Seok ^d  

^a Yonsei University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Konkuk University   (South Korea)

^d Kyungbok University   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Hispidin; Myocardial apoptosis; Oxidative stress; PKC inhibitor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; CARDIOVASCULAR AGENT; CASPASE 3; CATALASE; GLYCOGEN SYNTHASE KINASE 3BETA; HEME OXYGENASE 1; HISPIDIN; HOE 33342; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENOL DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; OXIDIZING AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PYRONE DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASSAY; CELL DEATH; CELL LOSS; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DEPHOSPHORYLATION; DRUG EFFECT; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HEART PROTECTION; MORPHOLOGY; MUSCLE CELL; MYOBLAST; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; XTT ASSAY; ANIMAL; CELL CULTURE; CELL PROLIFERATION; HEART MUSCLE CELL; METABOLISM; MYOCARDIAL APOPTOSIS; PATHOLOGY; PHOSPHORYLATION; PKC INHIBITOR; SPRAGUE DAWLEY RAT;

HISPIDIN; MYOCARDIAL APOPTOSIS; OXIDATIVE STRESS; PKC INHIBITOR;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; GLYCOGEN SYNTHASE KINASE 3; HYDROGEN PEROXIDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, CARDIAC; OXIDANTS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRONES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84907658711     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.07.037     Document Type: Article

References (50)

1. Mendis S., Lindholm L.H., Anderson S.G., Alwan A., Koju R., Onwubere B.J., Kayani A.M., Abeysinghe N., Duneas A., Tabagari S., Fan W., Sarraf-Zadegan N., Nordet P., Whitworth J., Heagerty A. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings. J. Clin. Epidemiol. 2011, 64:1451-1462.
2. Murphy E., Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 2008, 88:581-609.
3. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 1994, 94:1621-1628.
4. Sun B., Sun G.B., Xiao J., Chen R.C., Wang X., Wu Y., Cao L., Yang Z.H., Sun X.B. Isorhamnetin inhibits H(2)O(2)-induced activation of the intrinsicapoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation. J. Cell. Biochem. 2012, 113:473-485.
5. Takano H., Zou Y., Hasegawa H., Akazawa H., Nagai T., Komuro I. Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. Antioxid. Redox Signal. 2003, 5:789-794.
6. Tuteja N., Ahmad P., Panda B.B., Tuteja R. Genotoxic stress in plants: shedding light on DNA damage, repair and DNA repair helicases. Mutat. Res. 2009, 681:134-149.
7. Rodriguez-Sinovas A., Abdallah Y., Piper H.M., Garcia-Dorado D. Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction. Heart Fail. Rev. 2007, 12:207-216.
8. Zhu T., Kim S.H., Chen C.Y. A medicinal mushroom: Phellinus linteus. Curr. Med. Chem. 2008, 15:1330-1335.
9. Kim H.G., Yoon D.H., Lee W.H., Han S.K., Shrestha B., Kim C.H., Lim M.H., Chang W., Lim S., Choi S., Song W.O., Sung J.M., Hwang K.C., Kim T.W. Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-kappaB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophage. J. Ethnopharmacol. 2007, 114:307-315.
10. Ye S.F., Hou Z.Q., Zhang Q.Q. Protective effects of Phellinus linteus extract against iron overload-mediated oxidative stress in cultured rat hepatocytes. Phytother. Res. 2007, 21:948-953.
11. Gonindard C., Bergonzi C., Denier C., Sergheraert C., Klaebe A., Chavant L., Hollande E. Synthetic hispidin, a PKC inhibitor, is more cytotoxic toward cancer cells than normal cells in vitro. Cell Biol. Toxicol. 1997, 13:141-153.
12. Park I.H., Chung S.K., Lee K.B., Yoo Y.C., Kim S.K., Kim G.S., Song K.S. An antioxidant hispidin from the mycelial cultures of Phellinus linteus. Arch. Pharm. Res. 2004, 27:615-618.
13. Won K.J., Lin H.Y., Jung S., Cho S.M., Shin H.C., Bae Y.M., Lee S.H., Kim H.J., Jeon B.H., Kim B. Antifungal miconazole induces cardiotoxicity via inhibition of APE/Ref-1-related pathway in rat neonatal cardiomyocytes. Toxicol. Sci. 2012, 126:298-305.
14. 2-induced apoptosis through reactive oxygen species scavenging and Akt/GSK-3beta signaling pathway in H9c2 cardiomyocytes. Toxicol. Appl. Pharmacol. 2013, 268:90-98.
15. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
16. von Harsdorf R., Li P.F., Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999, 99:2934-2941.
17. Amaravadi R., Thompson C.B. The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest. 2005, 115:2618-2624.
18. Turner N.A., Xia F., Azhar G., Zhang X., Liu L., Wei J.Y. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells. J. Mol. Cell. Cardiol. 1998, 30:1789-1801.
19. Penna C., Mancardi D., Tullio F., Pagliaro P. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res. Cardiol. 2008, 103:368-377.
20. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 2000, 192:1001-1014.
21. Diplock A.T., Charleux J.L., Crozier-Willi G., Kok F.J., Rice-Evans C., Roberfroid M., Stahl W., Vina-Ribes J. Functional food science and defence against reactive oxidative species. Br. J. Nutr. 1998, 80(Suppl. 1):S77-112.
22. Lee I.K., Seok S.J., Kim W.K., Yun B.S. Hispidin derivatives from the mushroom Inonotus xeranticus and their antioxidant activity. J. Nat. Prod. 2006, 69:299-301.
23. Jang J.S., Lee J.S., Lee J.H., Kwon D.S., Lee K.E., Lee S.Y., Hong E.K. Hispidin produced from Phellinus linteus protects pancreatic beta-cells from damage by hydrogen peroxide. Arch. Pharm. Res. 2010, 33:853-861.
24. Martin A.R., Villegas I., La Casa C., de la Lastra C.A. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem. Pharmacol. 2004, 67:1399-1410.
25. McPhail D.B., Hartley R.C., Gardner P.T., Duthie G.G. Kinetic and stoichiometric assessment of the antioxidant activity of flavonoids by electron spin resonance spectroscopy. J. Agric. Food Chem. 2003, 51:1684-1690.
26. Chelikani P., Fita I., Loewen P.C. Diversity of structures and properties among catalases. Cell. Mol. Life Sci. 2004, 61:192-208.
27. Forstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5:338-349.
28. Kryston T.B., Georgiev A.B., Pissis P., Georgakilas A.G. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat. Res. 2011, 711:193-201.
29. Kuwana T., Newmeyer D.D. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr. Opin. Cell Biol. 2003, 15:691-699.
30. Sun X., Sun G.B., Wang M., Xiao J., Sun X.B. Protective effects of cynaroside against H(2)O(2)-induced apoptosis in H9c2 cardiomyoblasts. J. Cell. Biochem. 2011, 112:2019-2029.
31. Hausenloy D.J., Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc. Res. 2004, 61:448-460.
32. Armstrong S.C. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc. Res. 2004, 61:427-436.
33. Juhaszova M., Zorov D.B., Yaniv Y., Nuss H.B., Wang S., Sollott S.J. Role of glycogen synthase kinase-3beta in cardioprotection. Circ. Res. 2009, 104:1240-1252.
34. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
35. Badorff C., Ruetten H., Mueller S., Stahmer M., Gehring D., Jung F., Ihling C., Zeiher A.M., Dimmeler S. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J. Clin. Invest. 2002, 109:373-381.
36. Hirotani S., Zhai P., Tomita H., Galeotti J., Marquez J.P., Gao S., Hong C., Yatani A., Avila J., Sadoshima J. Inhibition of glycogen synthase kinase 3beta during heart failure is protective. Circ. Res. 2007, 101:1164-1174.
37. Kaga S., Zhan L., Altaf E., Maulik N. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J. Mol. Cell. Cardiol. 2006, 40:138-147.
38. Jeong J.J., Ha Y.M., Jin Y.C., Lee E.J., Kim J.S., Kim H.J., Seo H.G., Lee J.H, Kang S.S., Kim Y.S., Chang K.C. Rutin from Lonicera japonica inhibits myocardial ischemia/reperfusion-induced apoptosis in vivo and protects H9c2 cells against hydrogen peroxide-mediated injury via ERK1/2 and PI3K/Akt signals in vitro. Food Chem. Toxicol. 2009, 47:1569-1576.
39. Mayo L.D., Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. USA 2001, 98:11598-11603.
40. Yamaguchi H., Wang H.G. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001, 20:7779-7786.
41. * represses Bim expression independently of the JNK or PI3K pathways. Oncogene 2003, 22:1281-1293.
42. Terada K., Kaziro Y., Satoh T. Analysis of Ras-dependent signals that prevent caspase-3 activation and apoptosis induced by cytokine deprivation inhematopoietic cells. Biochem. Biophys. Res. Commun. 2000, 267:449-455.
43. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998, 282:1318-1321.
44. Saurin A.T., Pennington D.J., Raat N.J., Latchman D.S., Owen M.J., Marber M.S. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc. Res. 2002, 55:672-680.
45. Hahn H.S., Yussman M.G., Toyokawa T., Marreez Y., Barrett T.J., Hilty K.C., Osinska H., Robbins J., Dorn G.W. Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effects of in vivo deltaPKC inhibition. Circ. Res. 2002, 91:741-748.
46. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., Cavallaro G., Banci L., Guo Y., Bolli R., Dorn G.W., Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc. Natl. Acad. Sci. USA 2001, 98:11114-11119.
47. Peterman E.E., Taormina P., Harvey M., Young L.H. Go 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion. J. Cardiovasc. Pharmacol. 2004, 43:645-656.
48. Simonis G., Wiedemann S., Schwarz K., Christ T., Sedding D.G., Yu X., Marquetant R., Braun-Dullaeus R.C., Ravens U., Strasser R.H. Chelerythrine treatment influences the balance of pro- and anti-apoptotic signaling pathways in the remote myocardium after infarction. Mol. Cell. Biochem. 2008, 310:119-128.
49. Hug H., Sarre T.F. Protein kinase C isoenzymes: divergence in signal transduction?. Biochem. J. 1993, 291:329-343.
50. Numaguchi K., Shimokawa H., Nakaike R., Egashira K., Takeshita A. PKC inhibitors prevent endothelial dysfunction after myocardial ischemia-reperfusion in rats. Am. J. Physiol. 1996, 270:H1634-H1639.